Literature DB >> 1167783

Endocarditis caused by Rhodotorula successfully treated with 5-fluorocytosine.

Y Naveh, A Friedman, D Merzbach, N Hashman.   

Abstract

A 7-year-old boy suffering from aortic regurgitation and mitral stenosis and regurgitation was admitted with endocarditis caused by Rhodotorula pilimanae and was treated successfully with orally administered antifungal agent, namely 5-fluorocytosine (5-FC). A dose of 100 mg per kg body weight, divided into four equal parts, was prescribed. After a prolonged febrile period his temperature dropped to normal on the fourth day of 5-FC therapy. Review of the published reports disclosed few cases of endocarditis due to Rhodotorula spp. and this case seems to be the first treated with 5-FC. Follow-up in one year, after discharge from the hospital, revealed no evidence of relapse.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1167783      PMCID: PMC484161          DOI: 10.1136/hrt.37.1.101

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  10 in total

1.  Rhodotorula fungemia complicating staphylococcal endocarditis.

Authors:  P F SHELBURNE; R J CAREY
Journal:  JAMA       Date:  1962-04-07       Impact factor: 56.272

2.  Fungemia caused by certain nonpathogenic strains of the family Cryptococcaceae. Report of two cases due to Rhodotorula and Torulopsis glabrata.

Authors:  D B LOURIA; S M GREENBERG; D W MOLANDER
Journal:  N Engl J Med       Date:  1960-12-22       Impact factor: 91.245

3.  Use of 5-fluorocytosine in systemic candidiasis in infancy.

Authors:  M Isacson; Z Noah; J Faber; Y Herishano; L Gottfried
Journal:  Arch Dis Child       Date:  1972-12       Impact factor: 3.791

4.  Flucytosine.

Authors:  J P Utz
Journal:  N Engl J Med       Date:  1972-04-06       Impact factor: 91.245

5.  5-fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience.

Authors:  P L Steer; M I Marks; P D Klite; T C Eickhoff
Journal:  Ann Intern Med       Date:  1972-01       Impact factor: 25.391

6.  Treatment of Candida sepsis and Cryptococcus meningitis with 5-fluorocytosine. A new antifungal agent.

Authors:  D Tassel; M A Madoff
Journal:  JAMA       Date:  1968-10-21       Impact factor: 56.272

7.  Rhodotorula fungemia presenting as "endotoxic" shock.

Authors:  D A Leeber; I Scher
Journal:  Arch Intern Med       Date:  1969-01

8.  Candida endocarditis treated with 5-fluorocytosine.

Authors:  C O Record; J M Skinner; P Sleight; D C Speller
Journal:  Br Med J       Date:  1971-01-30

9.  5-fluorocytosine in the treatment of cryptococcal and candida mycoses.

Authors:  R J Fass; R L Perkins
Journal:  Ann Intern Med       Date:  1971-04       Impact factor: 25.391

10.  Infective endocarditis at the Presbyterian Hospital in New York City from 1938-1967.

Authors:  C E Cherubin; H C Neu
Journal:  Am J Med       Date:  1971-07       Impact factor: 4.965

  10 in total
  9 in total

1.  Activities of available and investigational antifungal agents against rhodotorula species.

Authors:  D J Diekema; B Petroelje; S A Messer; R J Hollis; M A Pfaller
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

2.  Microbiological characteristics and susceptibility patterns of strains of Rhodotorula isolated from clinical samples.

Authors:  F Galán-Sánchez; P García-Martos; C Rodríguez-Ramos; P Marín-Casanova; J Mira-Gutiérrez
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

Review 3.  Fungal endocarditis: patients at risk and their treatment.

Authors:  M S Seelig; P J Kozinin; P Goldberg; A R Berger
Journal:  Postgrad Med J       Date:  1979-09       Impact factor: 2.401

4.  Detection of extracellular phospholipase activity in Candida albicans and Rhodotorula rubra.

Authors:  P Mayser; S Laabs; K U Heuer; K Gründer
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

5.  Endocarditis caused by Rhodotorula infection.

Authors:  Matthew S Simon; Selin Somersan; Harjot K Singh; Barry Hartman; Brian L Wickes; Stephen G Jenkins; Thomas J Walsh; Audrey N Schuetz
Journal:  J Clin Microbiol       Date:  2013-11-06       Impact factor: 5.948

6.  Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of Rhodotorula isolates.

Authors:  Aimee K Zaas; Molly Boyce; Wiley Schell; Barbara Alexander Lodge; Jackie L Miller; John R Perfect
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

Review 7.  Fungal endocarditis in neonates and children.

Authors:  B C Millar; J Jugo; J E Moore
Journal:  Pediatr Cardiol       Date:  2005 Sep-Oct       Impact factor: 1.655

8.  Endocarditis due to Rhodotorula mucilaginosa in a kidney transplanted patient: case report and review of medical literature.

Authors:  Andrea Maria Cabral; Suzimar da Siveira Rioja; Fabio Brito-Santos; Juliana Ribeiro Peres da Silva; Maria Luíza MacDowell; Marcia S C Melhem; Ana Luíza Mattos-Guaraldi; Raphael Hirata Junior; Paulo Vieira Damasco
Journal:  JMM Case Rep       Date:  2017-11-02

9.  Meningitis caused by Rhodotorula mucilaginosa in human immunodeficiency virus seropositive patient.

Authors:  V P Baradkar; S Kumar
Journal:  Ann Indian Acad Neurol       Date:  2008-10       Impact factor: 1.383

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.